logo
GaldermaReceivesU.S.FDAApprovalforRestylaneLyftfortheEnhancementoftheChinProfile
===2025/11/5 21:22:08===
dy. At Month 3, 99.1% of investigators and 94.5% of subjects reported visible improvement. These results were maintained at Month 12, with 95.4% of investigators and 89.0% of patients continuing to report positive outcomes

At the end of the study (Month 12), a high proportion of patients agreed or strongly agreed that Restylane Lyft delivered natural-looking chin projection, improved the appearance of the lower face, and provided a smooth transition from chin to jawline, with satisfaction rates up to 86.3%

Restylane Lyft was well tolerated, with no unexpected or serious adverse events related to the product reported during the study, reinforcing its favorable safety profile









“The chin plays a vital role in overall facial harmony. Restylane Lyft offers a safe and effective way to enhance this area, helping to bring balance and definition to the face. It’s already a trusted
=*=*=*=*=*=
当前为第4/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页